Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
about
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mebendazole and a non-steroida ...... colon cancer preclinical model
@en
Mebendazole and a non-steroida ...... olon cancer preclinical model.
@nl
type
label
Mebendazole and a non-steroida ...... colon cancer preclinical model
@en
Mebendazole and a non-steroida ...... olon cancer preclinical model.
@nl
prefLabel
Mebendazole and a non-steroida ...... colon cancer preclinical model
@en
Mebendazole and a non-steroida ...... olon cancer preclinical model.
@nl
P2093
P2860
P356
P1433
P1476
Mebendazole and a non-steroida ...... colon cancer preclinical model
@en
P2093
David Huso
Gregory J Riggins
Ren-Yuan Bai
Tara Williamson
Verena Staedtke
P2860
P304
68571-68584
P356
10.18632/ONCOTARGET.11851
P407
P577
2016-09-06T00:00:00Z